Comparative study of cardiac electrophysiological effects of atrial natriuretic peptide

Valeria Kecskemeti, Pal Pacher, Csaba Pankucsi, Peter Nanasi

Research output: Contribution to journalArticle

30 Citations (Scopus)


The effects of atrial natriuretic peptide (ANP) on action potential characteristics were studied in various (human, rabbit, guinea-pig) atrial and guinea-pig right ventricular papillary muscles. ANP (1-100 nM) did not modify the resting membrane potential nor the maximum rate of depolarization phase (V(max)). Up to 10 nM, ANP dose-dependently decreased the action potential amplitude both in guinea-pig atrial and ventricular muscles, but it did not affect this parameter in the other atrial preparations. ANP caused a dose-dependent, marked decrease of action potential duration (APD) in practically every cardiac preparation studied (exception of guinea-pig left atrium). The strongest effect on APD can be observed in human atrial and guinea-pig ventricular fibers. The K+ channel blocker 4-aminopyridine (1 mM) and the ATP-dependent K+ channel inhibitor glibenclamide (10 μM) prevented the effect of ANP on APD in both ventricular atrial preparations. ANP prevented the appearance of isoprenaline (0.5 μM) induced slow AP in K+ depolarized myocardium. The present data suggest that ANP may inhibit the slow inward Ca2+ channel activity and facilitate the K+ channel activity.

Original languageEnglish
Pages (from-to)53-59
Number of pages7
JournalMolecular and Cellular Biochemistry
Publication statusPublished - Oct 19 1996



  • Atrial natriuretic peptide
  • Cardiac action potential
  • Glibenclamide
  • Human atrial muscle

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this